Jacobio Pharmaceuticals Co., Ltd.
Registry sponsor category
Industry
- Other names
- Jacobio Pharmaceuticals Co., Ltd.
- Company name
- Jacobio Pharmaceuticals Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (14)
- A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors
- A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
- A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors
- A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
- A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
- A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
- A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
- JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
- JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
- JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
- JAB-3068 Activity in Adult Patients With Advanced Solid Tumors
- JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
- Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations